Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

Mohamed Touati, MD, Jeremy Assenat, Jacques Monteil, MD, Philippe De Souza, MD, Magdalena Munyamahoro, Sandra Juge, Pierre-Marie Preux, MD, Arnaud Jaccard, MD, Dominique Bordessoule, MD

Blood (2014) 124 (21): 1323.

https://doi.org/10.1182/blood.V124.21.1323.1323

Published: 2014

Journal Articles

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

Marine Boulesteix, Mohamed Touati, Julie Abraham, Sandrine Verbeke, Assmae El Badaoui, Marie Pierre Gourin, Agnes Olivrie, Manuela Delage Corre, Benoit Marin, Arnaud Jaccard, Dominique Bordessoule, MD, PhD, Jacques Monteil

Blood (2012) 120 (21): 3632.

https://doi.org/10.1182/blood.V120.21.3632.3632

Published: 2012

Journal Articles

CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results

Mohamed Touati, Manuela Delage-Corre, Jacques Monteil, Agnes Olivrie-Gamaury, Stephane Moreau, Liliane Remenieras, Marie-Pierre Gourin, Julie Abraham, Nataliya Dmytruk, Arnaud Jaccard, Dominique Bordessoule

Blood (2011) 118 (21): 1558.

https://doi.org/10.1182/blood.V118.21.1558.1558

Published: 2011

Journal Articles

Non Predictive Value of An Initial Tc-99m-MIBI Scintigraphy On the Prediction of Therapeutic Outcome in Non Hodgkin and Hodgkin Lymphoma: Preliminary Results of a Prospective Study in 81 Patients .

Marie-Pierre Gourin, Jacques Monteil, Benoit Marin, Stéphane Girault, Natalya Dmytruk, Julie Abraham, Agnes Olivrie-Gamaury, Nicolas Weinbreck, Arnaud Jaccard, Jean Feuillard, Dominique Bordessoule, MD, PhD

Blood (2009) 114 (22): 4762.

https://doi.org/10.1182/blood.V114.22.4762.4762

Published: 2009

Journal Articles

Achievement a Negative 18-FDG/PET Status at the End of Procedure by Tailored Treatment According Pre-Transplantation Pet Status in Lymphomas Improve 5 Years-OS and EFS.

Dominique Bordessoule, Benoit Marin, Stéphane Girault, Fredericka Bompart, Julie Abraham, Natacha Dmytruck, Arnaud Jaccard, Jacques Monteil, Pascal Turlure

Blood (2008) 112 (11): 2193.

https://doi.org/10.1182/blood.V112.11.2193.2193

Published: 2008

NARROW

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results

Non Predictive Value of An Initial Tc-99m-MIBI Scintigraphy On the Prediction of Therapeutic Outcome in Non Hodgkin and Hodgkin Lymphoma: Preliminary Results of a Prospective Study in 81 Patients .

Achievement a Negative 18-FDG/PET Status at the End of Procedure by Tailored Treatment According Pre-Transplantation Pet Status in Lymphomas Improve 5 Years-OS and EFS.

Email alerts

ASH Publications

American Society of Hematology

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results

Non Predictive Value of An Initial Tc-99m-MIBI Scintigraphy On the Prediction of Therapeutic Outcome in Non Hodgkin and Hodgkin Lymphoma: Preliminary Results of a Prospective Study in 81 Patients .

Achievement a Negative 18-FDG/PET Status at the End of Procedure by Tailored Treatment According Pre-Transplantation Pet Status in Lymphomas Improve 5 Years-OS and EFS.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only